Benjamin R. Miller

Benjamin R. Miller

Auto-generated profile, based on publicly available information

Benjamin R. Miller

Department of Neurology, University of Minnesota, Minneapolis, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Neurosurgical Focus
Verified
Journal Article
Open access
PDF file
DBDavid J. Bonda
David J. Bonda
SMSunil Manjila
Sunil Manjila
PMPrachi Mehndiratta
Prachi Mehndiratta
FKFahd Khan
Fahd Khan
BMBenjamin R. Miller
Benjamin R. Miller
ICIgnazio Cali
Ignazio Cali
The human prion diseases, or transmissible spongiform encephalopathies, have captivated our imaginations since their discovery in the Fore linguistic group in Papua New Guinea in the 1950s. The mysterious and poorly understood “infectious protein” has become somewhat of a household name in many regions across the globe. From bovine spongiform encephalopathy (BSE), commonly identified as mad cow disease, to endocannibalism, media outlets have capitalized on these devastatingly fatal neurological conditions. Interestingly, since their discovery, there have been more than 492 incidents of iatrogenic transmission of prion diseases, largely resulting from prion-contaminated growth hormone and dura mater grafts. Although fewer than 9 cases of probable iatrogenic neurosurgical cases of Creutzfeldt-Jakob disease (CJD) have been reported worldwide, the likelihood of some missed cases and the potential for prion transmission by neurosurgery create considerable concern. Laboratory studies indicate that standard decontamination and sterilization procedures may be insufficient to completely remove infectivity from prion-contaminated instruments. In this unfortunate event, the instruments may transmit the prion disease to others. Much caution therefore should be taken in the absence of strong evidence against the presence of a prion disease in a neurosurgical patient. While the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) have devised risk assessment and decontamination protocols for the prevention of iatrogenic transmission of the prion diseases, incidents of possible exposure to prions have unfortunately occurred in the United States. In this article, the authors outline the historical discoveries that led from kuru to the identification and isolation of the pathological prion proteins in addition to providing a brief description of human prion diseases and iatrogenic forms of CJD, a brief history of prion disease nosocomial transmission, and a summary of the CDC and WHO guidelines for prevention of prion disease transmission and decontamination of prion-contaminated neurosurgical instruments.

1 September 2017 in Medical Hypotheses
Verified
Journal Article
Closed access
RRRwoof Reshi
Rwoof Reshi
CSChris Streib
Chris Streib
MEMustapha Ezzeddine
Mustapha Ezzeddine
MBMichelle Biros
Michelle Biros
BMBenjamin Miller
Benjamin Miller
AAAgnieszka Ardelt
Agnieszka Ardelt

26 November 2024 in Neurology
Verified
Journal Article
Closed access
BNBabak B. Navi
Babak B. Navi
CZCenai Zhang
Cenai Zhang
BMBenjamin R. Miller
Benjamin R. Miller
APAnokhi Pawar
Anokhi Pawar
MCMary Cushman
Mary Cushman
CSChristopher Streib
Christopher Streib
The objective of this study was to estimate the incidence, timing, and type of new cancer diagnosis among patients with cryptogenic stroke. We used data from the ARCADIA trial, which enrolled patients with cryptogenic stroke and atrial cardiopathy. Participants were prospectively followed, and serious adverse events were assessed every 3 months or sooner if investigators were alerted between visits to an event. Kaplan-Meier statistics were used to estimate the cumulative incidence of a cancer diagnosis within the first year after randomization. Among 878 participants without baseline history of cancer, 13 (1.5%) were diagnosed with incident cancer in the year after randomization, comprising 12 solid cancers (3 prostate, 2 breast, 2 gastrointestinal, and 5 other primary sites) and 1 hematologic cancer (non-Hodgkin lymphoma). The cumulative incidences of a cancer diagnosis were 0% at 3 months, 0.6% (95% CI 0.2%-1.5%) at 6 months, and 2.0% (95 CI 1.1%-3.4%) at 1 year. The median time from index stroke to cancer diagnosis was 261 days (interquartile range 183-358). In a multicenter cryptogenic stroke cohort with prospective follow-up, the 1-year cumulative incidence of a cancer diagnosis was 2%. This rate may be an underestimation because of the clinical trial population and exclusion of cancers diagnosed immediately after stroke. ClinicalTrials.gov Identifier: NCT03192215. Registered June 20, 2017. First patient enrolled February 1, 2018.

1 August 2015 in Stroke
Verified
Journal Article
Closed access
BMBenjamin R. Miller
Benjamin R. Miller
DSDaniel Strbian
Daniel Strbian
SSSophia Sundararajan
Sophia Sundararajan

1 August 2014 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
SMSunil Manjila
Sunil Manjila
BMBenjamin R. Miller
Benjamin R. Miller
AGAvi Goodman
Avi Goodman
BBBiji Bahuleyan
Biji Bahuleyan
MBMaysaa Basha
Maysaa Basha
JMJonathan P. Miller
Jonathan P. Miller

14 June 2022 in Communications Biology
Verified
Journal Article
Open access
PDF file
ILIvana Labounková
Ivana Labounková
RLRené Labounek
René Labounek
RKRadim Kolář
Radim Kolář
RTRalf P. Tornow
Ralf P. Tornow
CBCharles F. Babbs
Charles F. Babbs
INIgor Nestrasil
Igor Nestrasil
Theoretical models of retinal hemodynamics showed the modulation of retinal pulsatile patterns (RPPs) by heart rate (HR), yet in-vivo validation and scientific merit of this biological process is lacking. Such evidence is critical for result interpretation, study design, and (patho-)physiological modeling of human biology spanning applications in various medical specialties. In retinal hemodynamic video-recordings, we characterize the morphology of RPPs and assess the impact of modulation by HR or other variables. Principal component analysis isolated two RPPs, i.e., spontaneous venous pulsation (SVP) and optic cup pulsation (OCP). Heart rate modulated SVP and OCP morphology (pFDR < 0.05); age modulated SVP morphology (pFDR < 0.05). In addition, age and HR demonstrated the effect on between-group differences. This knowledge greatly affects future study designs, analyses of between-group differences in RPPs, and biophysical models investigating relationships between RPPs, intracranial, intraocular pressures, and cardiovascular physiology.